Display options
Share it on

Clin Epidemiol. 2018 Aug 27;10:1053-1071. doi: 10.2147/CLEP.S166309. eCollection 2018.

Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study.

Clinical epidemiology

Stine Bakkensen Bruun, Irene Petersen, Nickolaj Risbo Kristensen, Deirdre Cronin-Fenton, Alma Becic Pedersen

Affiliations

  1. Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, [email protected].
  2. Department of Primary Care and Population Health, University College London, London, UK.

PMID: 30214311 PMCID: PMC6118260 DOI: 10.2147/CLEP.S166309

Abstract

PURPOSE: To examine the association between selective serotonin reuptake inhibitor (SSRI) use and mortality, postoperative complications, and quality of in-hospital care in hip fracture patients.

PATIENTS AND METHODS: The study was a nationwide cohort study based on individual-level linked, prospectively collected data from Danish population-based national registries covering all hospitals in Denmark. The health care system in Denmark is tax-funded, and all citizens have equal access to health care services. We included patients with first-time hospitalization due to hip fracture undergoing surgery from 2006-2016. We estimated the risk of 30-day mortality, any unplanned readmission, any reoperation, specific postoperative complications including cardiovascular events and major bleeding, and quality of in-hospital care using Cox and Poisson regression analyses comparing current and former SSRI users with non-users.

RESULTS: In 68,487 hip fracture patients, 13,272 (19%) were current SSRI users, 2,777 (4%) were former SSRI users, and 52,438 (77%) were SSRI non-users. The 30-day mortality risk was 13% in current SSRI users (HR 1.16, 1.10-1.21) and 12% in former (HR 1.15, 1.04-1.27) compared with 10% in non-users. The HR for any unplanned readmission was 1.11 (1.02-1.20) in current and 1.13 (1.01-1.27) in former SSRI users and for any reoperation 1.21 (1.11-1.31) in current and 1.04 (0.84-1.28) in former SSRI users compared with non-users. The risk of venous thromboembolism, myocardial infarction, stroke, and bleeding were similar irrespective of SSRI use. No association between current and former SSRI use and quality of in-hospital care was found.

CONCLUSION: In patients undergoing hip fracture surgery, 30-day mortality and overall readmission risk were elevated in both current and former SSRI users compared with non-users. Those currently using SSRI had a 26% increased reoperation risk compared with non-users. However, SSRI use was not associated with increased risk of other postoperative complications and lower quality of in-hospital care. A limitation of this study was the inability to control for potential confounding of social deprivation.

Keywords: cohort studies; hip fracture; mortality; postoperative complications; quality of care; selective serotonin reuptake inhibitors

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. BMC Surg. 2010 Jan 24;10:3 - PubMed
  2. Clin Epidemiol. 2015 Nov 17;7:449-90 - PubMed
  3. Eur J Clin Pharmacol. 2015 Mar;71(3):369-75 - PubMed
  4. Am J Cardiol. 2011 Apr 1;107(7):972-9 - PubMed
  5. BMJ. 2011 Aug 02;343:d4551 - PubMed
  6. Heart Lung Circ. 2012 Apr;21(4):206-14 - PubMed
  7. BMC Med Res Methodol. 2011 May 28;11:83 - PubMed
  8. Arch Intern Med. 2002 Oct 14;162(18):2053-7 - PubMed
  9. J Clin Epidemiol. 2013 Mar;66(3):278-85 - PubMed
  10. Clin Epidemiol. 2012;4:303-13 - PubMed
  11. BMC Med Res Methodol. 2008 Oct 30;8:70 - PubMed
  12. J Clin Psychopharmacol. 2013 Dec;33(6):790-8 - PubMed
  13. JAMA Intern Med. 2013 Jun 24;173(12):1075-81 - PubMed
  14. J Chronic Dis. 1987;40(5):373-83 - PubMed
  15. Eur J Public Health. 2013 Aug;23(4):582-7 - PubMed
  16. BMC Health Serv Res. 2009 Oct 12;9:186 - PubMed
  17. Aging Clin Exp Res. 2008 Oct;20(5):412-8 - PubMed
  18. Eur J Epidemiol. 2014 Aug;29(8):541-9 - PubMed
  19. Epidemiology. 1994 Sep;5(5):541-4 - PubMed
  20. Int J Epidemiol. 2016 Dec 1;45(6):1866-1886 - PubMed
  21. Calcif Tissue Int. 2014 Jun;94(6):580-9 - PubMed
  22. Osteoporos Int. 2016 Sep;27(9):2727-2737 - PubMed
  23. Arch Intern Med. 2003 Oct 27;163(19):2354-8 - PubMed
  24. J Clin Psychopharmacol. 2013 Feb;33(1):31-7 - PubMed
  25. BMJ Open. 2016 Nov 18;6(11):e012832 - PubMed
  26. J Trauma. 2005 Dec;59(6):1283-90; discussion 1290-1 - PubMed
  27. Psychother Psychosom. 2017;86(5):268-282 - PubMed
  28. Epidemiol Rev. 2008;30:1-14 - PubMed
  29. BMJ. 2016 Apr 28;353:i1419 - PubMed
  30. PLoS One. 2013 Nov 15;8(11):e77975 - PubMed
  31. Clin Epidemiol. 2013 Dec 23;6:27-36 - PubMed
  32. Clin Epidemiol. 2017 Mar 15;9:157-166 - PubMed
  33. J Clin Epidemiol. 2005 Apr;58(4):323-37 - PubMed
  34. BMJ. 2005 Dec 10;331(7529):1374 - PubMed
  35. Anesthesiology. 2010 Mar;112(3):631-6 - PubMed

Publication Types